GEN Exclusives

More »

GEN News Highlights

More »
Feb 23, 2011

Covance and Ingenuity Systems Band Together to Improve NGS Data Analysis

  • Ingenuity® Systems and Covance Genomics Laboratory will work together to develop approaches that enhance next-generation sequencing (NGS) data. The aim is to obtain more actionable insights from NGS data and to answer research questions in a relevant biological context.

    The companies will develop new methodologies that integrate high-quality NGS data with industry-leading knowledge generation and management tools.  Ingenuity's IPA® software will be the used in the collaboration.

    Ingenuity says that IPA relieves the NGS data analysis bottleneck by providing the biological context necessary to move past the long noisy lists of genes, isoforms, and variants, helping to uncover those that are most critical to biology. The software allows researchers to analyze, integrate, and understand data derived from gene-expression, miRNA, and SNP microarrays; metabolomics and proteomics experiments; and small-scale experiments that generate gene and chemical lists.

    Privately held Ingenuity has won financing from investors that include Accel Partners
    Questmark Partners, Three Arch Partners, Bay City Capital, Morgan Stanley Capital Partners, and Oracle Venture Fund. Ingenuity has also received strategic investments from partners that include Millennium Pharmaceuticals and Affymetrix Corporation.

    Covance provides technologies for assessing gene expression and sequence variation in preclinical and clinical programs. The company says its technologies have run more than 450,000 samples to date.

    Publicly traded Covance finished the fourth quarter of 2010 with net income of $28.4 million, down nearly 32% from the year-ago quarter’s $41.5 million, largely reflecting $18.4 million in restructuring costs. Revenues for Q4 rose 2.4% over the same period in the previous year to $519.5 million.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?